Epidemiological aspects of allergic conjunctivitis
D Miyazaki, K Fukagawa, S Okamoto… - Allergology …, 2020 - jstage.jst.go.jp
abstract The prevalence of ocular allergies has been increasing worldwide for the past
several decades. The geographical distribution and hot spots of rhinoconjunctivitis have …
several decades. The geographical distribution and hot spots of rhinoconjunctivitis have …
Japanese guidelines for allergic conjunctival diseases 2017
E Takamura, E Uchio, N Ebihara, S Ohno… - Allergology …, 2017 - jstage.jst.go.jp
abstract The definition, classification, pathogenesis, test methods, clinical findings, criteria
for diagnosis, and therapies of allergic conjunctival disease are summarized based on the …
for diagnosis, and therapies of allergic conjunctival disease are summarized based on the …
Japanese guideline for allergic conjunctival diseases
E Takamura, E Uchio, N Ebihara, S Ohno… - Allergology …, 2011 - jstage.jst.go.jp
The definition, classification, pathogenesis, test methods, clinical findings, criteria for
diagnosis, and therapies of allergic conjunctival disease are summarized based on the …
diagnosis, and therapies of allergic conjunctival disease are summarized based on the …
A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis
Y Ohashi, N Ebihara, H Fujishima… - Journal of ocular …, 2010 - liebertpub.com
Aims: To examine the efficacy of tacrolimus ophthalmic suspension 0.1% in treating severe
allergic conjunctivitis. Methods: This was a multicenter, randomized, double-masked …
allergic conjunctivitis. Methods: This was a multicenter, randomized, double-masked …
Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement
A Fukushima, Y Ohashi, N Ebihara, E Uchio… - British Journal of …, 2014 - bjo.bmj.com
Background The objective of this study was to investigate the efficacy of topical 0.1%
tacrolimus in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal …
tacrolimus in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal …
A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis
N Ebihara, Y Ohashi, E Uchio, S Okamoto… - Journal of ocular …, 2009 - liebertpub.com
Purpose: To evaluate the effectiveness and safety of a novel cyclosporine 0.1% aqueous
ophthalmic solution in a large population with vernal keratoconjunctivitis (VKC) and atopic …
ophthalmic solution in a large population with vernal keratoconjunctivitis (VKC) and atopic …
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical α1-adrenoceptor antagonist
T Oshika, Y Ohashi, M Inamura, K Ohki… - American journal of …, 2007 - Elsevier
PURPOSE: To evaluate the incidence of Intraoperative Floppy Iris syndrome (IFIS) in
relation to the usage of α1-adrenoceptor antagonists. DESIGN: Prospective, interventional …
relation to the usage of α1-adrenoceptor antagonists. DESIGN: Prospective, interventional …
Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan
H Kaneko, T Suzutani, K Aoki, N Kitaichi… - British journal of …, 2011 - bjo.bmj.com
Background/aims New human adenovirus (HAdV)-54 causes epidemic keratoconjunctivitis
(EKC) and is virologically close to and has occasionally been detected as HAdV-8. Taking …
(EKC) and is virologically close to and has occasionally been detected as HAdV-8. Taking …
Japanese guidelines for allergic conjunctival diseases 2020
D Miyazaki, E Takamura, E Uchio, N Ebihara… - Allergology …, 2020 - jstage.jst.go.jp
abstract The definition, classification, pathogenesis, test methods, clinical findings, criteria
for diagnosis, and therapies of allergic conjunctival disease are summarized based on the …
for diagnosis, and therapies of allergic conjunctival disease are summarized based on the …
[HTML][HTML] Air pollution significantly associated with severe ocular allergic inflammatory diseases
D Miyazaki, K Fukagawa, A Fukushima, H Fujishima… - Scientific reports, 2019 - nature.com
Ambient air pollution is a well-recognized risk for various diseases including asthma and
heart diseases. However, it remains unclear whether air pollution may also be a risk of …
heart diseases. However, it remains unclear whether air pollution may also be a risk of …